MIRA Pharmaceuticals Ownership | Who Owns MIRA Pharmaceuticals?

MIRA Pharmaceuticals Ownership Summary

MIRA Pharmaceuticals is owned by 6.38% institutional investors, 16.71% insiders, and 76.91% retail investors. Vanguard group is the largest institutional shareholder, holding 3.43% of MIRA shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 0.94% of its assets in MIRA Pharmaceuticals shares.

MIRA Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	MIRA Pharmaceuticals	6.38%	16.71%	76.91%
Sector	Healthcare Stocks	50.53%	12.40%	37.07%
Industry	Drug Manufacturers - General Stocks	51.73%	3.54%	44.73%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Vanguard group	660.50K	3.43%	$997.35K
Cross staff investments	359.40K	1.52%	$384.56K
Geode capital management	290.89K	1.23%	$311.25K
Vanguard fiduciary trust	169.48K	0.72%	$181.35K
Blackrock funding, inc. /de	112.35K	0.47%	$120.21K
Northern trust	67.70K	0.29%	$72.44K
First american bank	60.00K	0.25%	$64.20K
State street	49.10K	0.21%	$52.54K
Xtx topco	37.57K	0.16%	$40.20K
Commonwealth equity services	35.07K	0.15%	$37.52K

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Cross staff investments	359.40K	0.19%	$384.56K
First american bank	60.00K	0.00%	$64.20K
International assets investment management	35.00K	0.00%	$37.10K
Virtu financial	12.20K	0.00%	$17.00K
Xtx topco	37.57K	0.00%	$40.20K
Cary street partners financial	10.00K	0.00%	$10.70K
Tower research capital llc (trc)	4.98K	0.00%	$5.32K
Commonwealth equity services	35.07K	0.00%	$37.52K
Two sigma securities	-	-	-
Eversource wealth advisors	-	-	-

Top Buyers

Holder	Shares	% Assets	Change
Vanguard group	660.50K	-	456.85K
Vanguard fiduciary trust	169.48K	-	169.48K
Susquehanna group, llp	25.15K	-	25.15K
Geode capital management	290.89K	-	18.01K
Xtx topco	37.57K	0.00%	16.67K

Top Sellers

Holder	Shares	% Assets	Change
Mirae asset global etfs	-	-	-312.78K
Suncoast equity management	-	-	-90.64K
Renaissance	-	-	-46.70K
J.w. cole advisors	-	-	-45.50K
Two sigma investments, lp	-	-	-27.04K

New Positions

Holder	Shares	% Assets	Change	Value
Vanguard fiduciary trust	169.48K	-	169.48K	$181.35K
Susquehanna group, llp	25.15K	-	25.15K	$26.91K
Virtu financial	12.20K	0.00%	12.20K	$17.00K
Fmr	115.00	-	115.00	$156.00
Caitong asset management	1.00	-	1.00	$1.00

Sold Out

Holder	Change
Jpmorgan chase	-16.00
Wells fargo & company/mn	-23.00
Eversource wealth advisors	-365.00
Fortitude family office	-773.00
Two sigma securities	-11.03K

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Mar 31, 2026	15	-40.00%	1,510,520	-31.85%	6	4.82%	7	-30.00%	1	-50.00%
Dec 31, 2025	15	-48.28%	1,379,943	-1.09%	7	10.61%	6	-68.42%	-	-100.00%
Sep 30, 2025	29	45.00%	1,395,159	39.51%	8	22.75%	19	111.11%	1	-75.00%
Jun 30, 2025	20	5.26%	1,000,074	3.26%	6	17.75%	9	12.50%	4	-20.00%
Mar 31, 2025	19	-17.39%	968,472	-13.53%	5	11.07%	8	-57.89%	5	400.00%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Total Stock Mkt Idx Inv	394.08K	0.94%	56.86K
Vanguard Morn Total Stk Mkt Idx Investor	394.08K	0.94%	56.86K
Vanguard MStar Total Stk Mkt Idx Invest	394.08K	0.94%	-
Vanguard Institutional Extnd Mkt Idx Tr	355.50K	0.85%	-
Fidelity Extended Market Index	149.50K	0.36%	9.63K
iShares Micro-Cap ETF	124.95K	0.30%	-1.67K
Extended Equity Market Fund E	109.77K	0.26%	-
Extended Equity Market Fund B	109.77K	0.26%	-
Blackrock Extended Mkt Fund CF	109.77K	0.26%	-
BlackRock Extended Equity Market Fund K	93.29K	0.22%	-171.00

Recent Insider Transactions

Date	Name	Role	Activity	Value
Nov 20, 2024	Aminov Erez	Chief Executive Officer	Sell	$56.63K
Nov 19, 2024	Aminov Erez	Chief Executive Officer	Sell	$77.02K
Aug 28, 2024	McNulty Brian Patrick	-	Sell	$392.00K
May 21, 2024	Aminov Erez	Chief Executive Officer	Buy	$808.00
May 21, 2024	Aminov Erez	Chief Executive Officer	Buy	$850.00

Insider Transactions Trends

Date	Buy	Sell
2026 Q1	-	-
2025 Q4	-	-
2025 Q3	-	-
2025 Q2	-	-
2024 Q4	-	2

MIRA Ownership FAQ

Who Owns MIRA Pharmaceuticals?

MIRA Pharmaceuticals shareholders are primarily institutional investors at 6.38%, followed by 16.71% insiders and 76.91% retail investors. The average institutional ownership in MIRA Pharmaceuticals's industry, Drug Manufacturers - General Stocks, is 51.73%, which MIRA Pharmaceuticals falls below.

Who owns the most shares of MIRA Pharmaceuticals?

MIRA Pharmaceuticals’s largest shareholders are Vanguard group (660.5K shares, 3.43%), Cross staff investments (359.4K shares, 1.52%), and Geode capital management (290.89K shares, 1.23%). Together, they hold 6.17% of MIRA Pharmaceuticals’s total shares outstanding.

Does Blackrock own MIRA Pharmaceuticals?

BlackRock is not among the top 10 institutional shareholders of MIRA Pharmaceuticals.

Who is MIRA Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Cross staff investments is MIRA Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 0.19% of its assets in 359.4K MIRA Pharmaceuticals shares, valued at 384.56K$.

Who is the top mutual fund holder of MIRA Pharmaceuticals shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of MIRA Pharmaceuticals shares, with 0.94% of its total shares outstanding invested in 394.08K MIRA Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools